How big is the Synthetic Biology Market?

The Synthetic Biology Market size is expected to reach USD 79.39 billion in 2024 and grow at a CAGR of 12.88% to reach USD 145.49 billion by 2029. Read More

What is the current Synthetic Biology Market size?

In 2024, the Synthetic Biology Market size is expected to reach USD 79.39 billion. Read More

Who are the key players in Synthetic Biology Market?

Genscript, Thermo Fisher Scientific Inc, Amyris Inc, Integrated DNA Technologies Inc. (Danaher Corporation) and Illumina, Inc. are the major companies operating in the Synthetic Biology Market. Read More

Which is the fastest growing region in Synthetic Biology Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Synthetic Biology Market?

In 2024, the North America accounts for the largest market share in Synthetic Biology Market. Read More

What years does this Synthetic Biology Market cover, and what was the market size in 2023?

In 2023, the Synthetic Biology Market size was estimated at USD 69.16 billion. The report covers the Synthetic Biology Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Synthetic Biology Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the top applications of Synthetic Biology beyond the pharmaceutical industry?

Biofuels, biomaterials, sustainable agriculture, and environmental remediation are the top applications of Synthetic Biology beyond the pharmaceutical industry. Read More

Synthetic Biology Market Share

Statistics for the 2023 & 2024 Synthetic Biology market share, created by Mordor Intelligence™ Industry Reports. Synthetic Biology share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Synthetic Biology Industry

The synthetic biology market is moderately consolidated due to a few companies operating globally and regionally. The competitive landscape includes an analysis of some international and local companies that hold market shares and are well known, including Genscript, Thermo Fisher Scientific Inc., Amyris Inc., Danaher Corporation (Integrated DNA Technologies Inc.), and Illumina Inc., Precigen Inc. (Intrexon Corporation), New England Biolabs Inc., Novozymes AS, Koninklijke DSM NV, and Viridos, Inc. (Synthetic Genomics Inc.).